Good Engineering Practice in Investment Management: Optimizing Pharma for the Future
What does it take to stay ahead in the volatile and fast world of pharmaceutical manufacturing? How do we ensure to invest smartly into the future? Join ISPE at the 2025 ISPE Europe Annual Conference, in London, United Kingdom, to hear about why the industry needs to look beyond just acquiring the latest, cutting-edge technology and how good engineering practices drive efficiency, compliance, and long-term sustainability of production sites and projects. The conference will bring together industry experts to:
- Discuss key challenges and opportunities in engineering
- Showcase award-winning projects
- Present case studies of risk reduction and Annex 1 implementation
- Explain how AI is leveraged in project management
The “Good Engineering Practice – Investment Management” track will provide attendees with actionable insights and aims to inspire professionals to improve their operations and processes while mitigating risks and to navigate industry trends and technologies to future-proof their strategies.
All attendees are welcome to join the sessions in this track, which covers various topics. Attendees will leave with practical takeaways ready for implementation. Professionals working in engineering, quality assurance, operations, compliance, or investment management will find it rewarding to check out the track’s planned content in detail:
Learning from Facility of the Year Awards (FOYA) winning projects
The FOYA program recognizes top performers in pharmaceutical facility engineering and operational efficiency. The sessions with showcase cutting-edge manufacturing improvements which can transform pharma operations globally.
- “Bridging Innovation and Compliance” will feature a presentation from Florian Keferböck with Takeda, who will present on the beePFS project that secured the FOYA Category Winner in Operations
- “FOYA Innovation,” presented by Ryan O’Sullivan with Eli Lilly and Company, will spotlight the case study on the 2024 FOYA overall award-winning submission
Mastering Risk and Project Management in Pharma
Successful project execution in pharma is all about balancing innovation with risk mitigation. These sessions will provide essential strategies to avoid common project pitfalls, reducing costly errors as well as inputs on how to evaluate your project management skills through AI:
- “Risk and Project Management in Pharma: Dos & Don'ts” will be presented by Maurizio Mangiarotti with the University of Siena and Leonardo Zanus with MAASI Enterprises
- “The Future Role of Artificial Intelligence in Project Management” will be presented by Gerhard Ortner, PhD, with the University of Vienna
Enabling Compliance and Facility Optimization via Good Engineering
Sessions in this track will enable pharmaceutical professionals to critically assess their current commissioning and qualification approach and evaluate whether these two fundamental components of engineering can be optimized in their teams. Further, attendees can gather engineering inspiration regarding facility design, which plays a crucial role in ensuring compliance and cost-effective manufacturing but also can allow for long-term sustainability of a site. Join ISPE to see how multi-product facilities which are arising more and more fit into the picture. Lastly, attendees can benefit from learning from implemented changes resulting to Annex 1 updates and how to shift from a state of regulatory theory and planning to actual execution with hearing about the lessons learned during implementation.
- “You Are Probably Doing Commissioning and Qualification (C&Q) Wrong” will be presented by Hazem Eleskandarani with CSL Behring and Mark Drinan with Takeda
- “Challenges and Opportunities in Multi-Product Facilities” will be presented by Theresa Ahern with Eli Lilly and Company
- “Aligning with Annex 1: Risk-Based Room Classifications and Sustainable Facility Design” will be presented by a representative from Lonza
Improving Processes and Exploring Decentralized Manufacturing
For many pharma professionals, legacy processes are a double-edged sword—they provide reliability but often lag behind in efficiency and compliance. The good engineering practices track also comprises of presentations tackling the modernization of existing processes which can help companies reduce risks and the potential of decentralized manufacturing which can help companies increase resilience, lower costs, and enhance supply chain agility.
- “Improving Legacy Processes: A Case Study on Reducing Risks” will be presented by Sebastian Scheler with Innerspace and Jeffrey Gensler with Kindeva Drug Delivery
- “Revolutionizing Pharmaceutical Production: The Power of Fleet Management in Distributed Manufacturing” will be presented by Line Lundsberg-Nielsen with Novo Nordisk and Novo Nordisk Engineering (NNE), Christian Siegmund with F. Hoffmann-La Roche, Sebastian Faller also with F. Hoffmann-La Roche, and Ryan Farley with Novo Nordisk
Why This Track is a Must-Attend in 2025
With the increasing complexity of pharma manufacturing, professionals must balance compliance, cost-efficiency, and innovation. Regulatory changes such as Annex 1 updates, the shift toward more flexible manufacturing facilities, and the adoption of AI in engineering and project management make it more critical than ever to stay informed.
Don’t miss this opportunity to stay informed, to challenge your mindset and current practices and to adapt new styles, lessons learned and technologies with the increasing complexity and competitivity in pharma manufacturing. Learn how to balance compliance (with regulatory changes like Annex 1 updates), cost-efficiency, innovation, and sustainability for more flexible manufacturing facilities with good engineering practices and clever investment management.
The future of pharma manufacturing is evolving—be a part of the conversation.
